Granules India Limited
$5.07
24H
Market Cap
Volume
Supply
Price Chart
About Granules India Limited - GRANULES.BO
Granules India Limited is a pharmaceutical company based in India that specializes in the production and manufacture of bulk drugs and pharmaceutical formulation intermediates, primarily focusing on over-the-counter and generic medications. They are known for their expertise in the production of paracetamol, ibuprofen, metformin, and other medicines distributed to various global markets.
What are Granules India Limited's core values and mission statement?
Granules India Limited's core values are focused on customer satisfaction, quality, teamwork, respect for individuals, and integrity. Their mission statement revolves around enhancing the quality of life of patients by providing affordable pharmaceutical products globally.
Who founded Granules India Limited and when?
Granules India Limited was founded by Krishna Prasad Chigurupati in 1984.
Who leads Granules India Limited?
As of the last update I have, Krishna Prasad Chigurupati was leading Granules India Limited in the capacity of Managing Director and Chairman.
Where is Granules India Limited located, and what is its base country?
Granules India Limited is headquartered in Hyderabad, India, which is its base country.
On which exchanges is Granules India Limited traded?
Granules India Limited is listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Historical data
Granules India Limited (GRANULES) Price Live Data
The live price of Granules India Limited (GRANULES) is $5.07, with a trading volume of 10,612 in the last 24 hours. Wrapstocks updates the GRANULES price in real-time. Granules India Limited is up 0.95% in the last 24 hours. The company has a live market cap of $1,228,091,195.88 and a supply of 242,368,992 GRANULES stocks.
Granules India Limited (GRANULES) is traded on Bombay Stock Exchange, and currently, the market is closed; trading will be resumed in 3 hours and 52 minutes.